JP2022533113A5 - - Google Patents

Info

Publication number
JP2022533113A5
JP2022533113A5 JP2021568170A JP2021568170A JP2022533113A5 JP 2022533113 A5 JP2022533113 A5 JP 2022533113A5 JP 2021568170 A JP2021568170 A JP 2021568170A JP 2021568170 A JP2021568170 A JP 2021568170A JP 2022533113 A5 JP2022533113 A5 JP 2022533113A5
Authority
JP
Japan
Prior art keywords
composition according
months
skin
composition
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021568170A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022533113A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/032458 external-priority patent/WO2020231983A1/en
Publication of JP2022533113A publication Critical patent/JP2022533113A/ja
Publication of JP2022533113A5 publication Critical patent/JP2022533113A5/ja
Priority to JP2025077186A priority Critical patent/JP2025118791A/ja
Pending legal-status Critical Current

Links

JP2021568170A 2019-05-14 2020-05-12 ピーク効果の遅延および／または応答持続時間の延長 Pending JP2022533113A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025077186A JP2025118791A (ja) 2019-05-14 2025-05-07 ピーク効果の遅延および／または応答持続時間の延長

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962847901P 2019-05-14 2019-05-14
US62/847,901 2019-05-14
PCT/US2020/032458 WO2020231983A1 (en) 2019-05-14 2020-05-12 Delaying peak effect and/or extending duration of response

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025077186A Division JP2025118791A (ja) 2019-05-14 2025-05-07 ピーク効果の遅延および／または応答持続時間の延長

Publications (2)

Publication Number Publication Date
JP2022533113A JP2022533113A (ja) 2022-07-21
JP2022533113A5 true JP2022533113A5 (https=) 2023-05-12

Family

ID=71094800

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021568170A Pending JP2022533113A (ja) 2019-05-14 2020-05-12 ピーク効果の遅延および／または応答持続時間の延長
JP2025077186A Pending JP2025118791A (ja) 2019-05-14 2025-05-07 ピーク効果の遅延および／または応答持続時間の延長

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025077186A Pending JP2025118791A (ja) 2019-05-14 2025-05-07 ピーク効果の遅延および／または応答持続時間の延長

Country Status (12)

Country Link
US (1) US20220296503A1 (https=)
EP (1) EP3969038A1 (https=)
JP (2) JP2022533113A (https=)
KR (1) KR20220008311A (https=)
CN (2) CN120919032A (https=)
AU (1) AU2020274082A1 (https=)
BR (1) BR112021022619A2 (https=)
CA (1) CA3139983A1 (https=)
IL (1) IL287988A (https=)
MX (1) MX2021012739A (https=)
SG (1) SG11202110518XA (https=)
WO (1) WO2020231983A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019005833A (es) 2016-11-21 2019-10-30 Eirion Therapeutics Inc Administracion transdermica de agentes grandes.
CN116925213B (zh) * 2023-09-12 2024-03-15 中国人民解放军军事科学院军事医学研究院 一种中和a型肉毒毒素的纳米抗体

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US296006A (en) 1884-04-01 John hoefleb
US4270537A (en) 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
CA1283827C (en) 1986-12-18 1991-05-07 Giorgio Cirelli Appliance for injection of liquid formulations
GB8704027D0 (en) 1987-02-20 1987-03-25 Owen Mumford Ltd Syringe needle combination
FR2638359A1 (fr) 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
US5008110A (en) 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5190521A (en) 1990-08-22 1993-03-02 Tecnol Medical Products, Inc. Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
SE9102652D0 (sv) 1991-09-13 1991-09-13 Kabi Pharmacia Ab Injection needle arrangement
US7384918B2 (en) 1991-09-24 2008-06-10 Allergan, Inc. Botulinum toxin for treating muscle contracture
US6939852B2 (en) 1991-09-24 2005-09-06 Allergan, Inc. Methods and compositions for the treatment of cerebral palsy
US5328483A (en) 1992-02-27 1994-07-12 Jacoby Richard M Intradermal injection device with medication and needle guard
US6010715A (en) 1992-04-01 2000-01-04 Bertek, Inc. Transdermal patch incorporating a polymer film incorporated with an active agent
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
IT1261849B (it) 1993-09-02 1996-06-03 Avantgarde Spa Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
US5512547A (en) 1994-10-13 1996-04-30 Wisconsin Alumni Research Foundation Pharmaceutical composition of botulinum neurotoxin and method of preparation
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
US5965154A (en) 1998-03-17 1999-10-12 Plc Holding, L.L.C. Adhesive matrix type transdermal patch and method of manufacturing same
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
US6908453B2 (en) 2002-01-15 2005-06-21 3M Innovative Properties Company Microneedle devices and methods of manufacture
US20040009180A1 (en) 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
MX2007010674A (es) 2005-03-03 2007-11-08 Revance Therapeutics Inc Composiciones y metodos para la aplicacion topica y el suministro transdermico de un oligopeptido.
KR102110379B1 (ko) 2005-12-01 2020-05-14 유니버시티 오브 메사츄세츠 로웰 보툴리눔 나노에멀젼
US8658391B2 (en) 2006-04-27 2014-02-25 Anterios, Inc. Assessment of the effects of topical administration of chemodenervating pharmaceuticals
US20120150023A1 (en) 2007-08-06 2012-06-14 Kaspar Roger L Microneedle arrays for active agent delivery
KR101848095B1 (ko) * 2008-06-26 2018-04-11 안테리오스, 인코퍼레이티드 경피 운반
KR101028457B1 (ko) * 2008-08-07 2011-04-14 (주)마이티시스템 미세바늘 교환형 미세바늘 롤러 및 스탬프
US20100196445A1 (en) 2008-11-12 2010-08-05 David Nathaniel E Systems and methods for delivery of biologically active agents
HUE037595T2 (hu) * 2008-12-31 2018-09-28 Revance Therapeutics Inc Injektálható botulinum toxin készítmények
US20120328701A1 (en) 2011-01-24 2012-12-27 Anterios, Inc. Nanoparticle compositions, formulations thereof, and uses therefor
BR112013018918A2 (pt) 2011-01-24 2016-10-04 Anterios Inc composições de nanopartículas
US9144671B2 (en) 2011-12-21 2015-09-29 3M Innovative Properties Company Transdermal adhesive patch assembly with removable microneedle array and method of using same
WO2015020982A2 (en) * 2013-08-04 2015-02-12 Aquavit Pharmaceuticals, Inc. Direct application system and method for the delivery of bioactive compositions and formulations
EP3368071B1 (en) * 2015-10-29 2022-01-26 ReVance Therapeutics, Inc. Injectable botulinum toxin formulations and methods of use thereof having long duration of therapeutic or cosmetic effect
US20170209553A1 (en) * 2016-01-22 2017-07-27 Transderm, Inc. Delivery of botulinum with microneedle arrays
MX2019005833A (es) * 2016-11-21 2019-10-30 Eirion Therapeutics Inc Administracion transdermica de agentes grandes.
AU2018222745B2 (en) 2017-02-17 2021-02-18 Allergan, Inc. Microneedle array with active ingredient

Similar Documents

Publication Publication Date Title
JP2022164750A5 (https=)
JP2022510007A5 (https=)
JP2019535829A5 (https=)
Fulton Jr The stimulation of postdermabrasion wound healing with stabilized aloe vera gel-polyethylene oxide dressing
FI3481852T3 (fi) Uusi botulinum-neurotoksiini ja sen johdannaisia
JP2022533113A5 (https=)
EP1185291B1 (de) Therapeutikum mit einem botulinum-neurotoxin
US20220218623A1 (en) Transdermal delivery of large agents
CA2510058A1 (en) Improved pharmaceutical botulinum toxin compositions
JP2002104990A (ja) 過度の発汗を処置するための医薬組成物
KR20140004186A (ko) 표면활성제 조성물
US20200054722A1 (en) Demonstrable efficacy across or within patient populations
WO2004017924A3 (en) Methods of treating involuntary facial spasms and facial wrinkles
Happle et al. Systemic retinoid therapy of systematized verrucous epidermal nevus
CN108114061B (zh) 中草药萃取物的用途与含此中草药萃取物与类固醇的医药组合物
Swinehart et al. Mometasone furoate lotion once daily versus triamcinolone acetonide lotion twice daily in psoriasis.
KR101480164B1 (ko) 쿠라리논 또는 고삼추출물을 포함하는 피부질환 예방 및 개선용 화장료 조성물
EP2928460A1 (en) Methods for preventing and treating inflammatory skin conditions
Armstrong et al. Efficacy of Ruxolitinib Cream for Treatment of Atopic Dermatitis in Children Aged 2 to 11 Years by Baseline Clinical Characteristics: Subgroup Analysis From a Randomized Phase 3 Study (TRuE-AD3)
Kesikoglu et al. Introduction to Botulinum Toxin’s Non-Cosmetic Indications
CN120302959A (zh) 修饰肽、组合物、抑制肌肉细胞收缩的方法、改善皮肤的方法和修饰肽的用途
Sillevis et al. The Time has come turn on the Cutaneous Nerve System to manage Pain
CN117085035A (zh) 一种能有效舒缓/修复敏感性肌肤、晒伤皮肤及医美术后受损皮肤的组合物及制备方法
CN118453838A (zh) 倭蛙皮肤抗氧化肽antioxidin-NV在制备皮肤抗炎、抗过敏的药物中的应用
Mori et al. Incobotulinum booster injections in patients with spasticity and dystonia after stroke